Skip to main content

Table 3 Antibodies and dilutions used

From: Lipid accumulation, lipid oxidation, and low plasma levels of acquired antibodies against oxidized lipids associate with degeneration and rupture of the intracranial aneurysm wall

Antigens

Type

Clone / Name

Dilut.

Origin

Double stains with

α-smooth muscle actin

mouse monoclonal

1A4

1:500

Sigma

HNE

CD45 (leukocyte antigen)

mouse monoclonal

2B11 + PD7/26

1:100

DAKO

Oil-Red-O

CD68 (macrophage)

mouse monoclonal

PG-M1

1:100

DAKO

15-LOX

15-Lipoxygenase

rabbit polyclonal

CheY

1:1000

(18)

CD68

Native or oxidized LDL epitopes

     

ApoB-100

mouse monoclonal

MB47

1:500

(10)

-

Minimally modified LDL

mouse monoclonal

Ox4E6

1:200-1000

(13)

1A4, YE

Copper oxidized LDL

guinea-pig polyclonal

YE

1:500

(14)

Ox4E6

Hydroxynonenal (OxLDL)

guinea-pig polyclonal

HNE

1:1000

(11)

1A4, MDA-2

Malondialdehyde (OxLDL)

mouse monoclonal

MDA-2

1:50

(11)

EO6

Natural anti-OxLDL IgM from ApoE mice

mouse monoclonal

EO6

1:500-1000

(12)

1A4, MDA2

  1. Sigma refers to Sigma-Aldrich Inc., St. Louis, MO. DAKO refers to DAKO A/S, Glostrup, Denmark. S-C refers to Santa-Cruz Biotechnology Inc, Santa-Cruz, CA, USA. For Anti-ApoB and oxidized LDL antibodies, the references were the antibodies were originally characterized are given in parentheses.